NCT00599079View on ClinicalTrials.gov

Azithromycin in the Treatment of M. Avium Complex Lung Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 1993

Primary Completion Date

May 31, 2008

Study Completion Date

May 18, 2017

Conditions
Mycobacterium Avium Complex Lung Disease
Interventions
DRUG

Azithromycin

Azithromycin Daily Dosage dependent on clinical factos such as age, weight and patient specific health descriptors

Trial Locations (1)

75708

The University of Texas Health Science Center at Tyler, Tyler

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

The University of Texas Health Science Center at Tyler

OTHER